{"product_id":"pinealon-10mg-vial","title":"Pinealon 20mg vial","description":"\u003cp data-start=\"356\" data-end=\"826\"\u003e \u003c\/p\u003e\n\u003cp data-start=\"356\" data-end=\"826\"\u003e\u003cstrong data-start=\"356\" data-end=\"368\"\u003ePinealon\u003c\/strong\u003e is a synthetic tripeptide composed of three amino acids: \u003cstrong data-start=\"426\" data-end=\"449\"\u003eglutamic acid (Glu)\u003c\/strong\u003e, \u003cstrong data-start=\"451\" data-end=\"474\"\u003easpartic acid (Asp)\u003c\/strong\u003e, and \u003cstrong data-start=\"480\" data-end=\"498\"\u003earginine (Arg)\u003c\/strong\u003e — chemically designated as \u003cstrong data-start=\"526\" data-end=\"533\"\u003eEDR\u003c\/strong\u003e. Originally developed by the \u003cstrong data-start=\"563\" data-end=\"624\"\u003eSt. Petersburg Institute of Bioregulation and Gerontology\u003c\/strong\u003e, Pinealon belongs to a broader class of \u003cstrong data-start=\"665\" data-end=\"700\"\u003eshort-chain regulatory peptides\u003c\/strong\u003e (a.k.a. \u003cstrong data-start=\"709\" data-end=\"734\"\u003epeptide bioregulators\u003c\/strong\u003e) intended to support \u003cstrong data-start=\"756\" data-end=\"800\"\u003egenomic stability, cellular regeneration\u003c\/strong\u003e, and \u003cstrong data-start=\"806\" data-end=\"825\"\u003eneuroprotection\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"828\" data-end=\"1125\"\u003ePinealon has drawn scientific interest due to its \u003cstrong data-start=\"878\" data-end=\"920\"\u003eepigenetic and cytoprotective activity\u003c\/strong\u003e, particularly in \u003cstrong data-start=\"938\" data-end=\"958\"\u003eneuronal tissues\u003c\/strong\u003e, making it a candidate for therapeutic use in \u003cstrong data-start=\"1005\" data-end=\"1038\"\u003eage-related cognitive decline\u003c\/strong\u003e, \u003cstrong data-start=\"1040\" data-end=\"1056\"\u003ebrain injury\u003c\/strong\u003e, \u003cstrong data-start=\"1058\" data-end=\"1083\"\u003ecircadian dysfunction\u003c\/strong\u003e, and \u003cstrong data-start=\"1089\" data-end=\"1124\"\u003eprenatal neurological disorders\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr data-start=\"1127\" data-end=\"1130\"\u003e\n\u003ch2 data-start=\"1132\" data-end=\"1172\"\u003e\u003cstrong data-start=\"1135\" data-end=\"1172\"\u003e2. Molecular Mechanisms of Action\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3 data-start=\"1174\" data-end=\"1228\"\u003e\u003cstrong data-start=\"1178\" data-end=\"1228\"\u003e2.1. Epigenetic Modulation and Gene Expression\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"1230\" data-end=\"1375\"\u003ePinealon acts at the \u003cstrong data-start=\"1251\" data-end=\"1268\"\u003enuclear level\u003c\/strong\u003e, influencing the \u003cstrong data-start=\"1286\" data-end=\"1374\"\u003eexpression of genes associated with brain development, memory, and stress resistance\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul data-start=\"1377\" data-end=\"1715\"\u003e\n\u003cli data-start=\"1377\" data-end=\"1478\"\u003e\n\u003cp data-start=\"1379\" data-end=\"1478\"\u003eBinds to \u003cstrong data-start=\"1388\" data-end=\"1411\"\u003eGC-rich DNA regions\u003c\/strong\u003e, potentially affecting the transcription of stress response genes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1479\" data-end=\"1574\"\u003e\n\u003cp data-start=\"1481\" data-end=\"1574\"\u003eActivates \u003cstrong data-start=\"1491\" data-end=\"1509\"\u003eRNA polymerase\u003c\/strong\u003e and \u003cstrong data-start=\"1514\" data-end=\"1537\"\u003ehistone acetylation\u003c\/strong\u003e, enhancing transcriptional activity.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1575\" data-end=\"1715\"\u003e\n\u003cp data-start=\"1577\" data-end=\"1605\"\u003eStimulates genes related to:\u003c\/p\u003e\n\u003cul data-start=\"1608\" data-end=\"1715\"\u003e\n\u003cli data-start=\"1608\" data-end=\"1630\"\u003e\n\u003cp data-start=\"1610\" data-end=\"1630\"\u003eRibosomal biogenesis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1633\" data-end=\"1673\"\u003e\n\u003cp data-start=\"1635\" data-end=\"1673\"\u003eAnti-apoptotic signaling (e.g., Bcl-2)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1676\" data-end=\"1715\"\u003e\n\u003cp data-start=\"1678\" data-end=\"1715\"\u003eNeuroplasticity (e.g., BDNF pathways)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1717\" data-end=\"1787\"\u003eThese effects may partially reverse \u003cstrong data-start=\"1753\" data-end=\"1786\"\u003eage-associated gene silencing\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch3 data-start=\"1789\" data-end=\"1839\"\u003e\u003cstrong data-start=\"1793\" data-end=\"1839\"\u003e2.2. Mitochondrial and Antioxidant Effects\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"1841\" data-end=\"2094\"\u003e\n\u003cli data-start=\"1841\" data-end=\"1919\"\u003e\n\u003cp data-start=\"1843\" data-end=\"1919\"\u003eReduces the intracellular accumulation of \u003cstrong data-start=\"1885\" data-end=\"1918\"\u003ereactive oxygen species (ROS)\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1920\" data-end=\"2003\"\u003e\n\u003cp data-start=\"1922\" data-end=\"2003\"\u003eIncreases \u003cstrong data-start=\"1932\" data-end=\"1962\"\u003esuperoxide dismutase (SOD)\u003c\/strong\u003e and \u003cstrong data-start=\"1967\" data-end=\"1993\"\u003eglutathione peroxidase\u003c\/strong\u003e activity.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2004\" data-end=\"2094\"\u003e\n\u003cp data-start=\"2006\" data-end=\"2094\"\u003eStabilizes mitochondrial membranes, reducing depolarization and improving ATP synthesis.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2096\" data-end=\"2178\"\u003eThis supports neuronal longevity by mitigating \u003cstrong data-start=\"2143\" data-end=\"2177\"\u003eoxidative and metabolic stress\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch3 data-start=\"2180\" data-end=\"2234\"\u003e\u003cstrong data-start=\"2184\" data-end=\"2234\"\u003e2.3. Anti-apoptotic and Neuroprotective Action\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"2236\" data-end=\"2501\"\u003e\n\u003cli data-start=\"2236\" data-end=\"2311\"\u003e\n\u003cp data-start=\"2238\" data-end=\"2311\"\u003eDownregulates \u003cstrong data-start=\"2252\" data-end=\"2272\"\u003ecaspase-3 and -9\u003c\/strong\u003e, key enzymes in the apoptotic cascade.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2312\" data-end=\"2400\"\u003e\n\u003cp data-start=\"2314\" data-end=\"2400\"\u003ePrevents DNA fragmentation and mitochondrial rupture in neuronally derived cell lines.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2401\" data-end=\"2501\"\u003e\n\u003cp data-start=\"2403\" data-end=\"2501\"\u003eProtects against \u003cstrong data-start=\"2420\" data-end=\"2438\"\u003eexcitotoxicity\u003c\/strong\u003e, such as that seen in stroke or traumatic brain injury models.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2503\" data-end=\"2578\"\u003eThese findings support its classification as a \u003cstrong data-start=\"2550\" data-end=\"2577\"\u003eneuroprotective peptide\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr data-start=\"2580\" data-end=\"2583\"\u003e\n\u003ch2 data-start=\"2585\" data-end=\"2644\"\u003e\u003cstrong data-start=\"2588\" data-end=\"2644\"\u003e3. Therapeutic Applications and Preclinical Evidence\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3 data-start=\"2646\" data-end=\"2693\"\u003e\u003cstrong data-start=\"2650\" data-end=\"2693\"\u003e3.1. Cognitive Aging and Memory Support\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"2695\" data-end=\"2955\"\u003e\n\u003cli data-start=\"2695\" data-end=\"2866\"\u003e\n\u003cp data-start=\"2697\" data-end=\"2758\"\u003eIn aged rodents, chronic administration of Pinealon improved:\u003c\/p\u003e\n\u003cul data-start=\"2761\" data-end=\"2866\"\u003e\n\u003cli data-start=\"2761\" data-end=\"2806\"\u003e\n\u003cp data-start=\"2763\" data-end=\"2806\"\u003e\u003cstrong data-start=\"2763\" data-end=\"2781\"\u003eSpatial memory\u003c\/strong\u003e in the Morris water maze\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2809\" data-end=\"2866\"\u003e\n\u003cp data-start=\"2811\" data-end=\"2866\"\u003e\u003cstrong data-start=\"2811\" data-end=\"2843\"\u003eLong-term potentiation (LTP)\u003c\/strong\u003e in hippocampal neurons\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2867\" data-end=\"2955\"\u003e\n\u003cp data-start=\"2869\" data-end=\"2955\"\u003eUpregulates gene expression linked to \u003cstrong data-start=\"2907\" data-end=\"2954\"\u003esynaptic integrity and memory consolidation\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2957\" data-end=\"3114\"\u003eThese findings suggest Pinealon as a \u003cstrong data-start=\"2994\" data-end=\"3022\"\u003egeroprotective nootropic\u003c\/strong\u003e, potentially suitable for age-related cognitive decline or early-stage Alzheimer’s disease.\u003c\/p\u003e\n\u003ch3 data-start=\"3116\" data-end=\"3169\"\u003e\u003cstrong data-start=\"3120\" data-end=\"3169\"\u003e3.2. Traumatic Brain Injury (TBI) and Hypoxia\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"3171\" data-end=\"3413\"\u003e\n\u003cli data-start=\"3171\" data-end=\"3247\"\u003e\n\u003cp data-start=\"3173\" data-end=\"3247\"\u003ePinealon reduces \u003cstrong data-start=\"3190\" data-end=\"3213\"\u003eneuronal cell death\u003c\/strong\u003e after hypoxic or ischemic events.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3248\" data-end=\"3318\"\u003e\n\u003cp data-start=\"3250\" data-end=\"3318\"\u003eDemonstrates improved neurological outcomes in rodent models of TBI.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3319\" data-end=\"3413\"\u003e\n\u003cp data-start=\"3321\" data-end=\"3413\"\u003eReduces post-injury \u003cstrong data-start=\"3341\" data-end=\"3362\"\u003eneuroinflammation\u003c\/strong\u003e, as indicated by lower IL-1β and TNF-α expression.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3415\" data-end=\"3505\"\u003eThis supports Pinealon’s use in \u003cstrong data-start=\"3447\" data-end=\"3479\"\u003eacute brain injury protocols\u003c\/strong\u003e or stroke rehabilitation.\u003c\/p\u003e\n\u003ch3 data-start=\"3507\" data-end=\"3558\"\u003e\u003cstrong data-start=\"3511\" data-end=\"3558\"\u003e3.3. Prenatal and Perinatal Neuroprotection\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"3560\" data-end=\"3885\"\u003e\n\u003cli data-start=\"3560\" data-end=\"3885\"\u003e\n\u003cp data-start=\"3562\" data-end=\"3686\"\u003eIn models of \u003cstrong data-start=\"3575\" data-end=\"3608\"\u003eprenatal hyperhomocysteinemia\u003c\/strong\u003e (a risk factor for developmental delay), maternal administration of Pinealon:\u003c\/p\u003e\n\u003cul data-start=\"3689\" data-end=\"3885\"\u003e\n\u003cli data-start=\"3689\" data-end=\"3760\"\u003e\n\u003cp data-start=\"3691\" data-end=\"3760\"\u003ePrevented structural and functional brain abnormalities in offspring.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3763\" data-end=\"3816\"\u003e\n\u003cp data-start=\"3765\" data-end=\"3816\"\u003eImproved learning and orientation tasks in progeny.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3819\" data-end=\"3885\"\u003e\n\u003cp data-start=\"3821\" data-end=\"3885\"\u003eReduced markers of oxidative stress in fetal hippocampal tissue.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3887\" data-end=\"3984\"\u003eImplication: potential as a \u003cstrong data-start=\"3915\" data-end=\"3954\"\u003ematernal neuroprotective supplement\u003c\/strong\u003e during high-risk pregnancies.\u003c\/p\u003e\n\u003ch3 data-start=\"3986\" data-end=\"4035\"\u003e\u003cstrong data-start=\"3990\" data-end=\"4035\"\u003e3.4. Circadian Rhythm and Sleep Disorders\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"4037\" data-end=\"4291\"\u003e\n\u003cli data-start=\"4037\" data-end=\"4109\"\u003e\n\u003cp data-start=\"4039\" data-end=\"4109\"\u003ePinealon influences \u003cstrong data-start=\"4059\" data-end=\"4082\"\u003emelatonin synthesis\u003c\/strong\u003e and pineal gland function.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4110\" data-end=\"4189\"\u003e\n\u003cp data-start=\"4112\" data-end=\"4189\"\u003eCorrects behavioral abnormalities induced by \u003cstrong data-start=\"4157\" data-end=\"4188\"\u003ecircadian rhythm disruption\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4190\" data-end=\"4291\"\u003e\n\u003cp data-start=\"4192\" data-end=\"4291\"\u003eMay support \u003cstrong data-start=\"4204\" data-end=\"4226\"\u003esleep architecture\u003c\/strong\u003e, neurohormonal synchronization, and \u003cstrong data-start=\"4263\" data-end=\"4290\"\u003echronobiological health\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4293\" data-end=\"4387\"\u003eThis suggests potential utility in \u003cstrong data-start=\"4328\" data-end=\"4386\"\u003esleep disorders, jet lag, and shift work maladaptation\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr data-start=\"4389\" data-end=\"4392\"\u003e\n\u003ch2 data-start=\"4394\" data-end=\"4443\"\u003e\u003cstrong data-start=\"4397\" data-end=\"4443\"\u003e4. Formulation, Administration, and Dosage\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-start=\"4445\" data-end=\"4841\"\u003e\n\u003cli data-start=\"4445\" data-end=\"4543\"\u003e\n\u003cp data-start=\"4447\" data-end=\"4543\"\u003e\u003cstrong data-start=\"4447\" data-end=\"4456\"\u003eForms\u003c\/strong\u003e: Available in \u003cstrong data-start=\"4471\" data-end=\"4488\"\u003eoral capsules\u003c\/strong\u003e, \u003cstrong data-start=\"4490\" data-end=\"4510\"\u003esublingual drops\u003c\/strong\u003e, or \u003cstrong data-start=\"4515\" data-end=\"4529\"\u003einjectable\u003c\/strong\u003e formulations.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4544\" data-end=\"4670\"\u003e\n\u003cp data-start=\"4546\" data-end=\"4670\"\u003e\u003cstrong data-start=\"4546\" data-end=\"4574\"\u003eRoutes of Administration\u003c\/strong\u003e: Oral for preventive health; injectable (typically intramuscular) for more intensive protocols.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4671\" data-end=\"4841\"\u003e\n\u003cp data-start=\"4673\" data-end=\"4691\"\u003e\u003cstrong data-start=\"4673\" data-end=\"4690\"\u003eTypical Doses\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul data-start=\"4694\" data-end=\"4841\"\u003e\n\u003cli data-start=\"4694\" data-end=\"4748\"\u003e\n\u003cp data-start=\"4696\" data-end=\"4748\"\u003ePreventive\/maintenance: 10–20 mg\/day for 10–30 days.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4751\" data-end=\"4841\"\u003e\n\u003cp data-start=\"4753\" data-end=\"4841\"\u003eFor acute interventions: 10 mg IM daily for up to 14 days (based on preclinical models).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4843\" data-end=\"4953\"\u003eNote: Clinical dosing is not formally standardized and is often extrapolated from Russian geriatric protocols.\u003c\/p\u003e\n\u003chr data-start=\"4955\" data-end=\"4958\"\u003e\n\u003ch2 data-start=\"4960\" data-end=\"4993\"\u003e\u003cstrong data-start=\"4963\" data-end=\"4993\"\u003e5. Safety and Tolerability\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3 data-start=\"4995\" data-end=\"5029\"\u003e\u003cstrong data-start=\"4999\" data-end=\"5029\"\u003e5.1. Toxicological Profile\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"5031\" data-end=\"5214\"\u003e\n\u003cli data-start=\"5031\" data-end=\"5095\"\u003e\n\u003cp data-start=\"5033\" data-end=\"5095\"\u003eNon-mutagenic and non-carcinogenic in long-term rodent models.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5096\" data-end=\"5160\"\u003e\n\u003cp data-start=\"5098\" data-end=\"5160\"\u003eNo observed adverse effects in chronic administration studies.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5161\" data-end=\"5214\"\u003e\n\u003cp data-start=\"5163\" data-end=\"5214\"\u003eSafe for use in both \u003cstrong data-start=\"5184\" data-end=\"5213\"\u003eyoung and elderly animals\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"5216\" data-end=\"5247\"\u003e\u003cstrong data-start=\"5220\" data-end=\"5247\"\u003e5.2. Human Tolerability\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-start=\"5249\" data-end=\"5523\"\u003e\n\u003cli data-start=\"5249\" data-end=\"5459\"\u003e\n\u003cp data-start=\"5251\" data-end=\"5342\"\u003ePreliminary human trials and case series (mostly from Russian medical literature) indicate:\u003c\/p\u003e\n\u003cul data-start=\"5345\" data-end=\"5459\"\u003e\n\u003cli data-start=\"5345\" data-end=\"5384\"\u003e\n\u003cp data-start=\"5347\" data-end=\"5384\"\u003eNo allergic or immunogenic reactions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5387\" data-end=\"5459\"\u003e\n\u003cp data-start=\"5389\" data-end=\"5459\"\u003eNo impact on liver enzymes, renal function, or hematological profiles.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5460\" data-end=\"5523\"\u003e\n\u003cp data-start=\"5462\" data-end=\"5523\"\u003eConsidered safe for \u003cstrong data-start=\"5482\" data-end=\"5522\"\u003eshort-term and cyclic administration\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"5525\" data-end=\"5528\"\u003e\n\u003ch2 data-start=\"5530\" data-end=\"5572\"\u003e\u003cstrong data-start=\"5533\" data-end=\"5572\"\u003e6. Regulatory and Commercial Status\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-start=\"5574\" data-end=\"5916\"\u003e\n\u003cli data-start=\"5574\" data-end=\"5615\"\u003e\n\u003cp data-start=\"5576\" data-end=\"5615\"\u003e\u003cstrong data-start=\"5576\" data-end=\"5604\"\u003eNot FDA- or EMA-approved\u003c\/strong\u003e as a drug.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5616\" data-end=\"5701\"\u003e\n\u003cp data-start=\"5618\" data-end=\"5701\"\u003eAvailable as a \u003cstrong data-start=\"5633\" data-end=\"5676\"\u003edietary supplement or research compound\u003c\/strong\u003e in select jurisdictions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5702\" data-end=\"5813\"\u003e\n\u003cp data-start=\"5704\" data-end=\"5813\"\u003eIncluded in \u003cstrong data-start=\"5716\" data-end=\"5756\"\u003eintegrative and anti-aging protocols\u003c\/strong\u003e in Russia, Ukraine, and some Eastern European countries.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5814\" data-end=\"5916\"\u003e\n\u003cp data-start=\"5816\" data-end=\"5916\"\u003eCommercially available under names like \u003cstrong data-start=\"5856\" data-end=\"5882\"\u003ePinealon®, EDR peptide\u003c\/strong\u003e, or \u003cstrong data-start=\"5887\" data-end=\"5915\"\u003ecerebral cortex peptides\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"5918\" data-end=\"6048\"\u003eClinicians should remain aware of jurisdictional limits and avoid therapeutic claims unless substantiated by regulatory oversight.\u003c\/p\u003e\n\u003chr data-start=\"6050\" data-end=\"6053\"\u003e\n\u003ch2 data-start=\"6055\" data-end=\"6094\"\u003e\u003cstrong data-start=\"6058\" data-end=\"6094\"\u003e7. Limitations and Research Gaps\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-start=\"6096\" data-end=\"6349\"\u003e\n\u003cli data-start=\"6096\" data-end=\"6152\"\u003e\n\u003cp data-start=\"6098\" data-end=\"6152\"\u003e\u003cstrong data-start=\"6098\" data-end=\"6129\"\u003eLack of Phase II\/III trials\u003c\/strong\u003e in Western populations\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6153\" data-end=\"6230\"\u003e\n\u003cp data-start=\"6155\" data-end=\"6230\"\u003eLimited access to raw clinical datasets (most studies published in Russian)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6231\" data-end=\"6282\"\u003e\n\u003cp data-start=\"6233\" data-end=\"6282\"\u003eVariable bioavailability depending on formulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6283\" data-end=\"6349\"\u003e\n\u003cp data-start=\"6285\" data-end=\"6349\"\u003eDosing regimens and long-term outcomes require formal validation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"6351\" data-end=\"6502\"\u003eDespite these limitations, the \u003cstrong data-start=\"6382\" data-end=\"6434\"\u003epreclinical and early clinical profile is strong\u003c\/strong\u003e, particularly in the context of \u003cstrong data-start=\"6467\" data-end=\"6501\"\u003enon-invasive neuroregeneration\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr data-start=\"6504\" data-end=\"6507\"\u003e\n\u003ch2 data-start=\"6509\" data-end=\"6529\"\u003e\u003cstrong data-start=\"6512\" data-end=\"6529\"\u003e8. Conclusion\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"6531\" data-end=\"6744\"\u003e\u003cstrong data-start=\"6531\" data-end=\"6543\"\u003ePinealon\u003c\/strong\u003e (Glu-Asp-Arg) is a scientifically intriguing tripeptide with a \u003cstrong data-start=\"6607\" data-end=\"6647\"\u003emultifaceted neuroprotective profile\u003c\/strong\u003e. Its actions at the genomic, mitochondrial, and neurochemical levels point to promising uses in:\u003c\/p\u003e\n\u003cul data-start=\"6746\" data-end=\"6859\"\u003e\n\u003cli data-start=\"6746\" data-end=\"6767\"\u003e\n\u003cp data-start=\"6748\" data-end=\"6767\"\u003e\u003cstrong data-start=\"6748\" data-end=\"6767\"\u003eCognitive aging\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6768\" data-end=\"6795\"\u003e\n\u003cp data-start=\"6770\" data-end=\"6795\"\u003e\u003cstrong data-start=\"6770\" data-end=\"6795\"\u003eBrain trauma recovery\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6796\" data-end=\"6826\"\u003e\n\u003cp data-start=\"6798\" data-end=\"6826\"\u003e\u003cstrong data-start=\"6798\" data-end=\"6826\"\u003ePrenatal neuroprotection\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6827\" data-end=\"6859\"\u003e\n\u003cp data-start=\"6829\" data-end=\"6859\"\u003e\u003cstrong data-start=\"6829\" data-end=\"6859\"\u003eChronobiological disorders\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"6861\" data-end=\"7145\"\u003eWhile robust regulatory approval is still pending, Pinealon’s unique \u003cstrong data-start=\"6930\" data-end=\"6954\"\u003eepigenetic mechanism\u003c\/strong\u003e, \u003cstrong data-start=\"6956\" data-end=\"6980\"\u003eantioxidant capacity\u003c\/strong\u003e, and \u003cstrong data-start=\"6986\" data-end=\"7011\"\u003eclinical tolerability\u003c\/strong\u003e mark it as a next-generation \u003cstrong data-start=\"7041\" data-end=\"7075\"\u003epeptide-based neurotherapeutic\u003c\/strong\u003e deserving of further international research and clinical exploration.\u003c\/p\u003e\n\u003chr data-start=\"7147\" data-end=\"7150\"\u003e\n\u003ch2 data-start=\"7152\" data-end=\"7184\"\u003e\u003cstrong data-start=\"7155\" data-end=\"7184\"\u003eKey Scientific References\u003c\/strong\u003e\u003c\/h2\u003e\n\u003col data-start=\"7186\" data-end=\"7994\"\u003e\n\u003cli data-start=\"7186\" data-end=\"7339\"\u003e\n\u003cp data-start=\"7189\" data-end=\"7339\"\u003eKhavinson V.K., et al. (2012). \u003cem data-start=\"7220\" data-end=\"7297\"\u003ePinealon peptide protects rat offspring from prenatal hyperhomocysteinemia.\u003c\/em\u003eNeurochemical Research, 37(4), 823–830.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7340\" data-end=\"7531\"\u003e\n\u003cp data-start=\"7343\" data-end=\"7531\"\u003eTrofimova S.V., et al. (2021). \u003cem data-start=\"7374\" data-end=\"7465\"\u003ePinealon peptide protects against oxidative stress-induced apoptosis in cortical neurons.\u003c\/em\u003e Bulletin of Experimental Biology and Medicine, 172(2), 206–210.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7532\" data-end=\"7674\"\u003e\n\u003cp data-start=\"7535\" data-end=\"7674\"\u003eObukhova L.K., et al. (2021). \u003cem data-start=\"7565\" data-end=\"7631\"\u003ePinealon’s modulation of circadian rhythm disruption in rodents.\u003c\/em\u003e Advances in Gerontology, 11(2), 111–119.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7675\" data-end=\"7795\"\u003e\n\u003cp data-start=\"7678\" data-end=\"7795\"\u003eKhavinson V.K. (2013). \u003cem data-start=\"7701\" data-end=\"7761\"\u003eShort peptides and gene expression in aging and longevity.\u003c\/em\u003e Biogerontology, 14(3), 219–225.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7796\" data-end=\"7994\"\u003e\n\u003cp data-start=\"7799\" data-end=\"7994\"\u003eResearchGate (2011). \u003cem data-start=\"7820\" data-end=\"7891\"\u003ePinealon increases cell viability by suppressing free radical levels.\u003c\/em\u003e\u003ca data-start=\"7892\" data-end=\"7994\" rel=\"noopener\" class=\"\" href=\"https:\/\/www.researchgate.net\/publication\/51698801\"\u003ehttps:\/\/www.researchgate.net\/publication\/51698801\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"RCpeptides","offers":[{"title":"Default Title","offer_id":52684859572562,"sku":null,"price":55.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/pinealon_20mg.png?v=1770834899","url":"https:\/\/sciencepeptideslab.com\/products\/pinealon-10mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}